Fernando De Benedetto Selected Research

buccalin

1/2014

Clinical efficacy and tolerability of an immune-stimulant(*) constituted by inactivated bacterial bodies in the prophylaxis of infectious episodes of airways: a double blind, placebo-controlled, randomized, multicentre study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fernando De Benedetto Research Topics

Disease

6	Chronic Obstructive Pulmonary Disease (COPD) 01/2018 - 01/2005
3	Dyspnea (Shortness of Breath) 01/2018 - 06/2013
1	Pulmonary Arterial Hypertension 01/2014
1	Edema (Dropsy) 01/2014
1	Infections 01/2014
1	Pulmonary Heart Disease (Cor Pulmonale) 01/2014
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2014
1	Respiratory Insufficiency (Respiratory Failure) 06/2013

Drug/Important Bio-Agent (IBA)

3	Oxygen (Dioxygen)IBA 01/2018 - 01/2014
2	coenzyme Q10 (CoQ10)IBA 01/2018 - 06/2013
2	AntioxidantsIBA 01/2018 - 01/2005
2	CreatineIBA 01/2018 - 06/2013
2	Bronchodilator Agents (Bronchodilators)IBA 01/2014 - 01/2014
1	PotassiumIBA 01/2018
1	SodiumIBA 01/2018
1	buccalinIBA 01/2014
1	Bacterial LysatesIBA 01/2014
1	SolutionsIBA 01/2014
1	UbiquinoneIBA 06/2013
1	Oxidants (Oxidizing Agents)IBA 01/2005
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2005
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2005

Therapy/Procedure

6	Therapeutics 01/2018 - 01/2005
2	Activities of Daily Living (ADL) 01/2018 - 06/2013
1	Noninvasive Ventilation 01/2014